NEUROPSYCHIATRY LATE-LIFE DEPRESSION GLUCOSE TOLERANCE GENOMICS METABOLOMICS BIOLOGICAL DATABASES PLATELETS INTEGRATED -OMICS BIOMARKER PANELS EPILEPTOGENESIS PROTEOME TRANSCRIPTOMICS PSYCHIATRY SUCCINYLATION MAJOR DEPRESSION DEPRESSION MASS SPECTROMETRY ELECTROPHORESIS DEEP VEIN THROMBOSIS TRANSPLANTATION CB2 NEUROBIOLOGY BIOENERGY MESIAL TEMPORAL LOBE EPILEPSY POSTMORTEM NEUROPSYCHIATRIC DISORDERS LC-MS-BASED PROTEOMICS POST-TRANSLATIONAL MODIFICATIONS BIOINFORMATICS TANDEM MASS SPECTROMETRY SEIZURES SHOTGUN PROTEOMICS ENRICHMENT ANALYSIS ASB MULTIFACTORIAL DISEASE BIOFUELS TOLERÂNCIA OPERACIONAL DIFFERENTIAL ANALYSIS LOCAL ANESTHETICS DATABASE DETERGENTS SIGNALING NETWORKS SCHIZOPHRENIA SGLT2 INHIBITORS BIOMARKERS LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY ANTIPSYCHOTICS MALONYLATION OMICS PERSONALIZED MEDICINE MALFORMATIONS OF CORTICAL DEVELOPMENT METABOLIC SYNDROME AGING EMPAGLIFLOZIN CANNABIDIOL CB1 SENESCENCE TYPE 1 DIABETES HIPPOCAMPAL SCLEROSIS SYSTEMS BIOLOGY CO-IMMUNOPRECIPITATION DRUG DELIVERY SYSTEMS AUTOTROPHY HETEROTROPHY BIOMASS ENDOCANNABINOIDS OPERATIONAL TOLERANCE